China’s ‘brain chip’ drive accelerates with slew of state-backed initiatives

China is rapidly advancing its brain chip technology through a series of state-backed initiatives, potentially outpacing Elon Musk's Neuralink in the race to commercialize the innovative medical devices. The country's government has announced multiple initiatives involving various parties, including state insurance companies, investment banks, and local governments.

PICC Property and Casualty, a major state-owned insurer, has signed the nation's first commercial insurance policy for the invasive surgery required to implant a brain-computer interface (BCI) in patients. The announcement has positively impacted the market, with BCI-related stocks in Hong Kong surging. BCI technology, which enables patients to control digital devices using their thoughts, has already been tested on human patients and shown promise in helping paraplegic individuals regain mobility.

However, clinicians stress that safety remains a top priority, as long-term safety data from clinical trials is still lacking. Meanwhile, the Zhejiang provincial government has announced plans to bolster financing support for BCI companies, encouraging them to go public. Zhejiang is home to several BCI start-ups, including BrainCo, which has raised over $292 million from global investors.

Researchers in China are also developing alternative implantation techniques, such as using a blood vessel like a stent, to avoid invasive brain surgery. In March, China's drug regulator granted market approval to Shanghai-based Neuracle Medical Technology for the country's first implantable BCI system, designed to restore hand motor function in patients with spinal cord injuries.